CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-15 | Birchler Brian EVP, Corp and Development Ops | Grant or award · Restricted Stock Unit | +20,400 | 58,328 | ||
| 2024-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +17,000 | 41,482 | ||
| 2024-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +20,400 | 41,814 | ||
| 2024-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Performance Restricted Stock Units | +17,000 | 29,290 | ||
| 2024-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Restricted Stock Unit | +20,400 | 67,661 | ||
| 2024-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Restricted Stock Unit | +1,800 | 5,762 | ||
| 2024-01-15 | Baroldi Joseph EVP, Chief Business Officer | Grant or award · Restricted Stock Unit | +2,625 | 8,387 | ||
| 2024-01-12 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Exercise or conversion 10b5-1 | +8,000 | $32.60 | $261K | 46,170 |
| 2024-01-12 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale 10b5-1 | −8,000 | $53.50 | $428K | 38,170 |
| 2024-01-12 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −8,000 | 24,265 | ||
| 2024-01-02 | Swayze Eric EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +27,200 | 27,200 | ||
| 2024-01-02 | Swayze Eric EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +154 | 154 | ||
| 2024-01-02 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award · Non-Qualified Stock Option (right to buy) | +27,200 | 27,200 |
Page 44 of 44 · 873 trades